NIH-funded research NIH-funded research

Investigating how B cells respond to different antigens

Official title: Core B: Antigen Receptor Sequencing, Cloning, Expression, and Analysis Core

Funded at University of Alabama at Birmingham · NIH-11075846 · Data updated 2026-11-12

This study is looking at how special immune cells called B cells work and change when they encounter things like infections or transplants, which could help improve treatments for people with immune system issues.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham
NIH-funded
Lab location1 site (Birmingham, United States)
Project startApril 16, 2024
Project endMarch 31, 2029
Funding year2025
Award (this year)$434,363
NIH project number5U19AI181105-02
Project IDNIH-11075846 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals undergoing organ transplants or those with autoimmune disorders who may benefit from enhanced understanding of their immune responses.

Less likely to help

Patients with stable, non-immune related conditions may not receive direct benefits from this research.

What this research studies

This research focuses on understanding the behavior of B cells, which are crucial components of the immune system that produce antibodies. By analyzing the unique receptors on B cells, researchers aim to track how these cells expand and adapt in response to various antigens, including those from transplants and infections. The study employs advanced sequencing techniques to gather detailed information about B cell receptor diversity and functionality, which could lead to improved treatments for conditions involving immune responses. Patients may benefit from insights gained into how their immune systems react to different challenges.

Why it matters

Potential benefit: If successful, this research could lead to better strategies for managing immune responses in patients, particularly in transplant settings or autoimmune diseases.

How similar studies have gone: Previous research has shown promising results in understanding B cell responses through similar sequencing approaches, indicating a strong potential for success in this area.

Where this research is happening

  • University of Alabama at Birmingham
    Birmingham, United States
    Active

Researchers

  • Principal investigator: King, Rodney Glenn — University of Alabama at Birmingham
  • Study coordinator: King, Rodney Glenn

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.